Macular Society: The first patients to receive a new treatment derived from stem cells for people with wet age-related macular degeneration (AMD) have regained enough vision to be able to read.

20 March 2018
Source: Macular Society

Macular Society Logo

The first patients to receive a new treatment derived from stem cells for people with wet age-related macular degeneration (AMD) have regained enough vision to be able to read.

The study is a major milestone for the London Project to Cure Blindness, which was funded by the Macular Society in 2008.

AMD is the most common cause of sight loss in the UK, and can lead to a rapid loss of central (reading) vision. The two patients who underwent the procedure, a woman in her early 60s and a man in his 80s, had wet AMD and declining vision.

The study investigated whether the diseased cells at the back the patients’ affected eye could be replenished using the stem cell based patch. A specially engineered surgical tool was used to insert the patch under the retina in the affected eye of each patient in an operation lasting one to two hours.

The patients were monitored for 12 months and reported improvements to their vision. They went from not being able to read at all even with glasses, to reading 60-80 words per minute with normal reading glasses.

Read the full story on the Macular Society Website

Related Posts